Related references
Note: Only part of the references are listed.Molecular Recognition of the Catalytic Zinc(II) Ion in MMP-13: Structure-Based Evolution of an Allosteric Inhibitor to Dual Binding Mode Inhibitors with Improved Lipophilic Ligand Efficiencies
Thomas Fischer et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Crystal structure of full-length human collagenase 3 (MMP-13) with peptides in the active site defines exosites in the catalytic domain
Enrico A. Stura et al.
FASEB JOURNAL (2013)
The relationship of metalloproteinase gene polymorphisms and lung cancer
Maruf Sanli et al.
JOURNAL OF SURGICAL RESEARCH (2013)
Collagenase-3 (MMP-13) deficiency protects C57BL/6 mice from antibody-induced arthritis
Anjana Singh et al.
ARTHRITIS RESEARCH & THERAPY (2013)
Triple-Negative Breast Cancer: Clinical and Histological Correlations
Zeinab Elsawaf et al.
BREAST CARE (2011)
Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis
Mark E. Schnute et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
MMP13 as a stromal mediator in controlling persistent angiogenesis in skin carcinoma
Wiltrud Lederle et al.
CARCINOGENESIS (2010)
Novel selective MMP-13 inhibitors reduce collagen degradation in bovine articular and human osteoarthritis cartilage explants
Dorothea Piecha et al.
INFLAMMATION RESEARCH (2010)
Overexpression of BDNF and TrkB in human bladder cancer specimens
Pei Chun Lai et al.
ONCOLOGY REPORTS (2010)
Cheminformatics-Based Drug Design Approach for Identification of Inhibitors Targeting the Characteristic Residues of MMP-13 Hemopexin Domain
Roopa Kothapalli et al.
PLOS ONE (2010)
A pathway-based classification of human breast cancer
Michael L. Gatza et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
Aleix Prat et al.
BREAST CANCER RESEARCH (2010)
Identification of Specific Hemopexin-like Domain Residues That Facilitate Matrix Metalloproteinase Collagenolytic Activity
Janelle L. Lauer-Fields et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Selective modulation of matrix metalloproteinase 9 (MMP-9) functions via exosite inhibition
Janelle L. Lauer-Fields et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Progress in matrix metalloproteinase research
Gillian Murphy et al.
MOLECULAR ASPECTS OF MEDICINE (2008)
Synthetic active site-directed inhibitors of metzincins: Achievement and perspectives
Athanasios Yiotakis et al.
MOLECULAR ASPECTS OF MEDICINE (2008)
Reappraising metalloproteinases in rheumatoid arthritis and osteoarthritis: destruction or repair?
Gillian Murphy et al.
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2008)
Discovery and characterization of a novel inhibitor of matrix metalloprotease-13 that reduces cartilage damage in vivo without joint fibroplasia side effects
Adam R. Johnson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Triple-helical transition state analogues: A new class of selective matrix metalloproteinase inhibitors
Janelle Lauer-Fields et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2007)
Intrinsic genetic characteristics determine tumor-modifying capacity of fibroblasts: matrix metalloproteinase-3 5A/5A genotype enhances breast cancer cell invasion
Deborah L. Holliday et al.
BREAST CANCER RESEARCH (2007)
Structure and function of matrix metalloproteinases and TIMPs
H Nagase et al.
CARDIOVASCULAR RESEARCH (2006)
MMP13 mutation causes spondyloepimetaphyseal dysplasia, Missouri type (SEMDMO)
AM Kennedy et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Collagenase unwinds triple-helical collagen prior to peptide bond hydrolysis
LD Chung et al.
EMBO JOURNAL (2004)
Altered endochondral bone development in matrix metalloproteinase 13-deficient mice
D Stickens et al.
DEVELOPMENT (2004)
Strategies for MMP inhibition in cancer:: Innovations for the post-trial era
CM Overall et al.
NATURE REVIEWS CANCER (2002)
Heparin-enhanced zymographic detection of matrilysin and collagenases
WH Yu et al.
ANALYTICAL BIOCHEMISTRY (2001)
Structure-based design of a novel, potent, and selective inhibitor for MMP-13 utilizing NMR spectroscopy and computer-aided molecular design
JM Chen et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2000)
The in vitro activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3
A Amour et al.
FEBS LETTERS (2000)
Specific expression of matrix metalloproteinases 1, 3, 9 and 13 associated with invasiveness of breast cancer cells in vitro
M Balduyck et al.
CLINICAL & EXPERIMENTAL METASTASIS (2000)
Share Paper
